NCT00143364 - A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation | Biotech Hunter

Enrollment

1,005

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

March 31, 2005

Conditions

Smoking Cessation

Interventions

DRUG

varenicline (CP-526,555)

Trial Locations (15)

Pfizer Investigational Site, Palo Alto

Pfizer Investigational Site, San Diego

Pfizer Investigational Site, Denver

Pfizer Investigational Site, Pembroke Pines

Pfizer Investigational Site, Indianapolis

Pfizer Investigational Site, Portland

Pfizer Investigational Site, Boston

Pfizer Investigational Site, Albert Lea

Pfizer Investigational Site, Rochester

Pfizer Investigational Site, New York

Pfizer Investigational Site, Rochester

Pfizer Investigational Site, Providence

Pfizer Investigational Site, Nashville

Pfizer Investigational Site, Madison

Pfizer Investigational Site, Milwaukee